关键词： Gary Phillips Pharmaxis
2013年3月13日讯 /生物谷BIOON/ --澳大利亚生物制药公司Pharmaxis公司日前宣布，鉴于当前公司不佳的经营状况，公司CEO Dr. Alan Robertson已经离任。公司决定将由现任COO Gary Phillips来接任CEO一职并重新审视公司的经营策略。（生物谷Bioon.com）
详细英文报道：
Facing down a recent FDA advisory committee vote against Bronchitol, Australia's Pharmaxis says that it has found a new CEO and is reviewing its business strategy. Dr. Alan Robertson has left the company and is being replaced by COO Gary Phillips, according to the Sydney Morning Herald. "Pharmaxis is facing likely delays in the commercialization of Bronchitol in the United States," Chairman Malcolm McComas said. The penny stock declined slightly on the news.
(责任编辑：yangtao)
